Take a closer look: https://bit.ly/4iZNzUa
The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved for two MS types.
@msnewstoday.bsky.social
@msnewstoday.bsky.socialTake a closer look: https://bit.ly/4iZNzUa
The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved for two MS types.
@mgnews.bsky.socialDiscover more: https://bit.ly/4xU2AKQ
Columnist Sarah Bendiff can sense a myashtenia gravis flare-up before one happens and knows that living with the disease means being prepared.
#MyastheniaGravis #RareDisease #MG #MyastheniaGravisNews #Bionews
@alsnewstoday.bsky.socialDiscover more: https://bit.ly/4jtayXO
Advocates are cheering as legislation to renew the ACT for ALS headed to President Trump's desk days before the program is set to expire.
@mgnews.bsky.socialA small adjustment in your plans can be an act of courage: https://bit.ly/4oXeFeg
#MyastheniaGravis #MyastheniaGravisNews #Bionews #ChronicIllnessCommunity
@mgnews.bsky.socialFatigue with myasthenia gravis can affect much more than how much someone sleeps.
Connect with others who understand life with MG in the MG News Forums: https://bit.ly/47db7xP
#MyastheniaGravis #ChronicIllness #MGCommunity #MyastheniaGravisNews #Bionews
@alsnewstoday.bsky.socialKiersten, who lives with Friedreich’s ataxia (FA), speaks to that unseen exhaustion and why understanding from others can matter.
Join the ALS News Today Forums to connect with others affected by ALS: https://bit.ly/47daX9H
@angioedemanews.bsky.socialDiscover more: https://bit.ly/3W0Sfzn
Hereditary angioedema should be considered in children with recurrent severe abdominal pain and vomiting, the case of a young boy shows.
@msnewstoday.bsky.socialGet the scoop: https://bit.ly/4yqdlpj
An estimated 3.1 million people worldwide are now living with MS, up from about 2.8 million in 2020 and 1.8 million in 2013, a report shows.
@mgnews.bsky.socialTake a closer look: https://bit.ly/4hVRGQ2
Cemdisiran lowered hospitalization rates and reduced the number of myasthenic crises for gMG patients, a global clinical trial showed.
#MyastheniaGravis #RareDisease #MG #MyastheniaGravisNews #Bionews
@alsnewstoday.bsky.socialExplore the details: https://bit.ly/4hTaM9r
A walk past fruit trees reminds columnist Kristin Neva of her father, and she thinks about what will remind her children of their dad.
@angioedemanews.bsky.socialDiscover how to navigate intimacy and angioedema: https://bit.ly/43DYuLc
Your condition doesn’t define your worth—take charge of your sexual and emotional well-being, one step at a time.
#Angioedema #SexualHealth #ChronicIllness #PatientSupport #RareDisease #AngioedemaNews #Bionews
@mgnews.bsky.social'Fine' isn't enough: https://bit.ly/4va2L4t
#MyastheniaGravisNews #Bionews #ChronicIllnessCommunity #MGStrong #MGSupport
@mgnews.bsky.socialA quiet breath for the relief that comes with finally being believed: https://bit.ly/48gxROw
#MyastheniaGravis
#MGCommunity #MyastheniaGravisNews #Bionews #AdvocacyHealthcare
@mgnews.bsky.socialA quiet moment of validation for symptoms others can’t see: https://bit.ly/4oEZy9s
#MyastheniaGravis
#MGCommunity #MyastheniaGravisNews #Bionews #MGTreatment
@angioedemanews.bsky.socialGene therapy could transform HAE treatment: https://bit.ly/4mxg8aV
#GeneTherapy #HAETreatment #InnovationInMedicine #RareDiseaseTreatment #MedicalAdvances #AngioedemaNews #Bionews
@msnewstoday.bsky.socialGet the scoop: https://bit.ly/4hlq3jd
Having MS results in columnist Desiree Lama waging a sometimes silent battle against pain, but she's learning to listen to her body's cues.
@mgnews.bsky.socialGet the scoop: https://bit.ly/3Ttxdsz
Trying to get an Ultomiris infusion reminds columnist Mark Harrington how navigating MG can leave him feeling stressed out and worn down.
#MyastheniaGravis #RareDisease #MG #MyastheniaGravisNews #Bionews
@mgnews.bsky.socialA little space to acknowledge how unpredictable MG weakness can be🫶: https://bit.ly/4rj7kXu
#MyastheniaGravisNews #Bionews #ChronicIllnessCommunity #MGStrong #MGSupport #InvisibleIllness #ChronicIllnessWarrior #MGJourney #MGWarrior #ChronicIllness
@msnewstoday.bsky.socialTake a closer look: https://bit.ly/4rCpkgW
Experimental therapy kamuvudine-9 (K-9), derived from antiviral drugs, restored lost mobility and vision in a preclinical MS study.
@mgnews.bsky.socialTake a closer look: https://bit.ly/4yhNP5A
The experimental CAR T-cell therapy miv-cel led to sustained disease control for people with generalized myasthenia gravis in a recent trial.
#MyastheniaGravis #RareDisease #MG #MyastheniaGravisNews #Bionews